About the Project
In Aim 1, we will intensively examine the immune microenvironments of high-risk sarcoma patients enrolled in the ZERO Childhood Cancer Program, by combining DNA and RNA sequencing analysis with multiplex immunohistochemistry. This unique and complex dataset will allow us, for the first time, to obtain a comprehensive understanding of the immune profiles of high-risk paediatric sarcomas, identifying subsets of immune-inflamed “hot” and non-inflamed “cold” tumours, and pinpointing the most clinically relevant and targetable immune checkpoints.
In Aim 2, this data will be used to inform the design of new immunotherapeutic strategies to test in pre-clinical immunocompetent models of sarcomas, initially in fusion-positive and fusion-negative models of rhabdomyosarcoma, and osteosarcoma. We expect that immune-inflamed “hot” tumours will respond well to immune checkpoint inhibitors as monotherapy, while non-inflamed “cold” tumours will require combination therapy with other immunomodulatory drugs to achieve optimal results.
This research project will present a new paradigm for the treatment of high-risk sarcomas, with the long-term goal of translating immune profile-based treatment approaches into the clinic in a personalised setting.
All students at the Institute must fulfil the requirements for enrolment at UNSW to undertake their PhD with us as well as obtain a scholarship that will cover both your living expenses and tuition fees. Scholarship and entry requirements will be provided on request.
Why not add a message here
Based on your current searches we recommend the following search filters.
Based on your current search criteria we thought you might be interested in these.